Sichenzia Ross Ference LLP

Author Archives: Sichenzia Ross Ference LLP

Sichenzia Ross Ference LLP is a full service law firm with a nationally recognized corporate, securities and litigation practice that provides experienced representation in all matters involving the securities industry.  In addition to handling routine to complex commercial matters, SRF’s renowned litigation department specializes in defending companies and individuals against all types of securities cases, including class action lawsuits, shareholder derivative actions, and matters involving allegations of fraud, misrepresentation or other securities violations.  The litigation team has also brought defamation lawsuits against companies and individuals related to market manipulation.  Additionally, it represents individuals and companies in investigations by the Securities and Exchange Commission (SEC) and other regulatory bodies.  The litigation team has a robust practice representing brokers and broker-dealers in arbitrations before the Financial Industry Regulatory Authority (FINRA).  These arbitrations typically involve claims of unsuitability, churning, unauthorized trading and other allegations of broker misconduct.  Finally, SRF has a burgeoning expungement practice, where it represents brokers seeking to have negative and harmful customer complaints removed from their industry records.  The firm complements its core practice areas with an established commercial real estate and trusts and estates practice. Visit SRF's LinkedIn page

Sichenzia Ross Ference LLP代表FINRA成员公司以300万美元注册直接提供General Cannabis Corp.的普通股和认股权证

Press Release­­ – New York, NY – June 4, 2019 – Sichenzia Ross Ference LLP (SRF) announced today that it has represented a FINRA member firm as financial advisor in the registered direct offering of 3.0 million shares of common stock and 3.0 million warrants of General Cannabis Corp. (OTCQX: CANN) at a price of $1.00 per share for gross proceeds of approximately $3.0 million.

continue reading >>

Sichenzia Ross Ference LLP以800万美元的私人配售代表AIT Therapeutics

AIT therapeutics

Press Release – New York, NY – June 4, 2019 – Sichenzia Ross Ference LLP announced today that it has represented AIT Therapeutics, Inc. (NASDAQ:AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions including serious lung infections and pulmonary hypertension, in a $8 million private placement of its common stock.

continue reading >>

Sichenzia Ross Ference LLP宣布以130万美元私募配售Medivist Diversited REIT,Inc。

medalist diversified logo

Press Release – New York, NY – May 31, 2019 –  Sichenzia Ross Ference LLP announced today that it has represented Aegis Capital Corp. as placement agent in a private offering of 270,833 shares of Common Stock of Medalist Diversified REIT, Inc. (NASDAQ: MDRR) at a purchase price of $4.80 per share for gross proceeds of approximately $1.3 million.

continue reading >>

Sichenzia Ross Ference诉讼合伙人Marc Ross和Scott Furst在多年南安普顿房地产争议案中代表客户多次上诉

新闻稿 – 纽约州纽约市 – 2019年5月30日Sichenzia Ross Ference LLP(SRF)诉讼合伙人Marc RossScott Furst以及上诉法律顾问在向纽约最高法院,上诉庭:第二司法部门提出的多项上诉中胜诉部门。这些上诉试图扭转萨福克县审判法院否决一项动议,驳回2015年由邻近的财产所有人提起的诉讼,这些财产所有者寻求并由审判法庭判决,禁止正在建造的俯瞰Shinnecock Bay的住宅建筑。南安普敦。关于财产及其遵守当地分区法律有关高度和挫折要求的早期相关诉讼最终未能解决争议,并引发即时诉讼,当时SRF被上诉人聘请接管诉讼。。

continue reading >>

Sichenzia Ross Ference LLP代表Genetic Technologies Limited(ASX:GTG;纳斯达克股票代码:GENE)发行120万美元美国存托股票

genetic technologies logo

Press Release – New York, NY – May 23, 2019 –  Sichenzia Ross Ference LLP announced today that it represented Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE), a diversified molecular diagnostics company, in a registered direct offering of American Depositary Shares (“ADSs”) and warrants to purchase ADSs.  The Company received gross proceeds of approximately $1,200,000.

continue reading >>

Sichenzia Ross Ference LLP以800万美元公开发行Medalist Diversited REIT,Inc。的普通股代表Aegis Capital Corp.

medalist diversified logo

Press Release – New York, NY – May 14, 2019 –  Sichenzia Ross Ference LLP (SRF) announced today that it has represented Aegis Capital Corp. as sole book-running manager in the underwritten public offering of 1.66 million shares Common Stock of Medalist Diversified REIT, Inc.(NASDAQ: MDRR) at a price of $4.80 per share for gross proceeds of $8.0 million.

continue reading >>

诉讼合伙人Scott Furst在$ 10,000,000保险纠纷中成功胜诉

新闻稿-纽约州,纽约-2019年5月9日-席恩奇亚·罗斯·弗朗斯(SRF)诉讼合伙人斯科特·弗斯特(Scott Furst)成功败诉了向纽约最高法院上诉庭第二司法部门提起的上诉,该上诉试图撤消初审法院的上诉。完全撤消一项多方,多方索赔的损害赔偿诉讼,并撤销和恢复大约一千万美元的保险金($ 10,000,000.00)。原告提出的索赔包括欺诈,违反合同以及针对保险代理人,保险代理机构和保险人的《纽约州保险法》。原告于2014年7月开始诉讼,在近五年的诉讼中,Furst先生代表代理人和代理机构成功地驳回了原告的申诉,击败了续签和重新启动的动议,并驳回了经修正的申诉。从中提起上诉。第二部门以多种理由驳回了上诉,特别强调了被告与原告的指控相抵触的证据。法院还得出结论,根据法律,原告不能对代理人或代理人提出索赔。第二部门还根据SRF提出的事实和法律,申明初审法院作出了对保险人和原告有利的简易判决,并提起上诉

Odierna诉RSK,LLC,2019 N.Y. App。师LEXIS 2573(预计于2019年2月发布)。

daniel scott furst
Latest posts by daniel scott furst (see all)

    Sichenzia Ross Ference LLP代表Quest Solutions,Inc。进行500万美元私募

    quest solution

    新闻稿 – 纽约州纽约市 – 2019年4月9日 – Sichenzia Ross Ference LLP今天宣布,已代表Quest Solution,Inc。(OTCQB:QUES)以购买价格私募配售其普通股的16,666,667股未注册股份每股$ .30,总收益约5,000,000美元。投资者还获得了以每股0.35美元的行使价购买16,666,667股普通股的认股权证。

    continue reading >>

    Sichenzia Ross Ference LLP代表New Age Beverages Corp.与东西岸的2500万美元信贷工具

    new age beverage corp. logo

    新闻稿 – 纽约,纽约 –  2019年4月2日 – Sichenzia Ross Ference LLP今天宣布,它已代表New Age Beverages Corporation(纳斯达克“NBEV”)与East West Bank达成贷款和担保协议,该协议提供高达2500万美元的资金总本金额循环信贷额度,包括1500万美元的定期贷款和一项特征,如果公司选择使用它并提供1000万美元的循环信贷额度,则可提供额外的1000万美元

    continue reading >>

    Sichenzia Ross Ference LLP宣布其2019年对ThinkEquity 会议进行白金级赞助

    新闻稿 – 纽约,纽约 – 2019年3月29日 – Sichenzia Ross Ference LLP很高兴的宣布,
    他们将对2019年ThinkEquity会议进行白金级赞助。会议将于2019年5月2日在纽约州纽约
    市的文华东方酒店举行。

    SRF的创始合伙人之一Gregory Sichenzia评论道:“我们长期以来一直是ThinkEquity的朋
    友,很高兴能够支持其不断发展的系列会议。”

    Sichenzia Ross Ference LLP
    Latest posts by Sichenzia Ross Ference LLP (see all)

      Sichenzia Ross Ference LLP代表LiveWell Canada Inc.以 1500万美元的私人配售来扩展其CBD业务

      live well

      新闻稿 – 纽约,纽约 – 2019年3月28日 – 领先的证券和公司法律师事务所Sichenzia Ross
      Ference LLP今天宣布,它已代表LiveWell Canada Inc.(“LiveWell”)公司,一家在加拿大证券交易所上市的、正在进入美国市场的加拿大CBD公司,在私人配售中向机构投资 者提供高级担保可换股票据,总收益总额为1500万美元,其中包括LiveWell之前达成的 300万美元过桥融资。

      continue reading >>

      Sichenzia Ross Ference LLP代表Aegis Capital Corp.以 540万美元公开发行Opgen, Inc.普通股。

      opgen logo

      新闻稿 – 纽约,纽约 – 2019年3月28日 – Sichenzia Ross Ference LLP今天宣布,它
      已代表Aegis Capital Corp.,使其作为唯一的账面管理经理,承销公开发行900万股的
      Opgen,Inc.普通股(纳斯达克股票代码:OPGN),以每股0.60美元的价格,总收益为540
      万美元。 Opgen是一家精准医药公司,利用分子诊断的力量来对抗传染病。 Sichenzia
      Ross Ference LLP团队由合伙人Tom Rose,合伙人Gregory Sichenzia和合伙人Jay
      Yamamoto领导。

      Sichenzia Ross Ference LLP
      Latest posts by Sichenzia Ross Ference LLP (see all)

        Sichenzia Ross Ference代表Pareteum Corporation与Post Road Group共同进行5000万美元的信贷投资

        The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

        新闻稿 – 纽约州纽约市 – 2019年3月20日 – 全美知名的证券和公司法律师事务所
        Sichenzia Ross Ference LLP今天宣布,它已代表全球云软件通信平台公司Pareteum
        Corporation(纳斯达克股票代码:TEUM),与Post Road Group达成50,000,000美元的
        高级担保信贷额度。根据信贷额度,Post Road于2019年2月26日向Pareteum提供了
        25,000,000美元的初始贷款,并在Pareteum在初始资助日18周年之前提出额外贷款,增
        量为5,000,000美元。

        Sichenzia Ross Ference LLP团队由合伙人Darrin Ocasio、合伙人Avital Perlman,及其
        同事Grant Levine律师和Huan Lou律师领导。

        Sichenzia Ross Ference LLP
        Latest posts by Sichenzia Ross Ference LLP (see all)

          创始合伙人Marc Ross出席有关大麻,麻和CBD在州和联邦法律规定中的冲突的法律网络研讨会

          新闻稿 – 纽约州纽约市 –  2019年3月11日在全美范围广受认可的证券和公司法律所,Sichenzia Ross Ference LLP今天宣布其创始合伙人Marc J. Ross将出席由Clear Law Institute举办网络研会课程,“州法律使娱乐和/或医用大麻使用合法化与联邦受控物质法之间的相互作用”,时间是2019年3月11日星期一下午3:00。

          (受持续法律教育(“CLE”)认可的)演讲,将讨论州和联邦法律之间的冲突及其对大麻行业以及大麻和CBD行业的影响。

          要注册并参加此次网络研讨会,请访问此处的网站该网站包括扬声器代码MRoss152493,可享有35%的折扣。

          Sichenzia Ross Ference LLP
          Latest posts by Sichenzia Ross Ference LLP (see all)

             

            Murky大麻银行图片最终会变得更清晰吗?

            美国联邦储备委员会主席杰罗姆·鲍威尔昨天在2019年2月26日星期二在国会作证时,明确承认由于州和联邦法律相互冲突,一家从事大麻或大麻相关业务的公司进入银行业的不确定性和紧张局势。当被问及这个话题时,主席说:“我认为明确是很好的,”并补充道,“金融机构及其监管机构和监管机构处于困境,大麻根据联邦法律是非法的,根据一些州法律是合法的“。

            此外,上周,众议院金融服务委员会举行了有史以来第一次关于大麻和金融服务的听证会,创造了历史。该听证会的讨论是安全和公平执法(SAFE)银行法案的新草案。去年,国会推出了2017年的“国家外汇管理局法案”,该法案陷入停滞,无处可去。该法案的主要赞助商科罗拉多州众议员Ed Perlmutter近六年来一直在介绍该法案的一个版本,但直到现在才开始听证会。今年,不仅要讨论法案,而且该法案更加强大,特别是为为大麻相关业务提供产品和服务的辅助企业增加保护。

            正如财政部长史蒂芬姆努钦去年在国会作证时明确表示,他也希望大麻企业能够获得银行服务。 “我向你们保证,我们不想要现金袋,”他去年在众议院委员会面前表示。 “我们希望找到一个解决方案,以确保拥有大量现金的企业有办法让他们进入存款机构,以确保安全。”

            今天,虽然10个州和哥伦比亚特区使休闲大麻合法化,但大麻在联邦一级仍然是非法的,被列为附表1药物,以及海洛因和迷幻剂。而且,虽然越来越多的金融机构愿意为大麻和大麻相关业务提供银行服务,但仍然存在一种在行业范围内无法参与的主要因素,无论是因为需要增加的合规性,还是因为限制不明确由财政部颁布的。

            Marc J. Ross, Esq.
            Latest posts by Marc J. Ross, Esq. (see all)

              Sichenzia Ross Ference代表Pareteum Corporation收购iPass, Inc.的股份并完成收购

              The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

              新闻稿 – 纽约州纽约市 – 2019年2月14日 – 全美认可的证券和公司法律公司Sichenzia Ross
              Ference LLP今天宣布,它代表Pareteum公司(纳斯达克股票代码:TEUM),一个云软件平台
              ,接受了iPass, Inc.的交换股份(纳斯达克股票代码:IPAS),iPass, Inc.是全球移动连接提供商

              continue reading >>

              Sichenzia Ross Ference合伙人Ralph Preite参与Financial Poise举办的“法律道德 – 关于 技术的最佳实践”网络研讨会

              新闻稿 – 纽约州纽约市 – 2019年2月14日 – Sichenzia Ross Ference LLP合伙人Ralph Preite参加
              了2月13日举办的Financial Poise的“法律道德 – 关于技术的最佳实践”网络研讨会。

              本次网络研讨会系列探讨了企业在各种背景下面临的道德问题,从所谓的“灰色地带”到涉及彻底
              腐败的问题。小组成员考虑并推荐不同的道德决策方法和律师在为商业客户提供建议方面的作用

              要了解更多信息,请点击这里。

              Sichenzia Ross Ference LLP加入Jeff D’Angelo担任公司和证券合伙人

              纽约,2019年2月13日(GLOBE NEWSWIRE) – 领先的证券法和公司法律师事务所Sichenzia Ross Ference今天宣布,Jeff D'Angelo将加入该公司,成为该公司企业和证券业务的合伙人,于2019年2月19日起生效。

              在加入SRF之前,D'Angelo先生曾在上市公司Document Security Systems,Inc。担任过各种职务,包括副总裁兼总法律顾问。在加入DSS之前,D'Angelo先生曾执业多年,并担任Prudential Financial的董事总经理,负责其纽约州西部地区的金融业务,并监督60多位销售人员和经理。

              D'Angelo先生将代表SRF在证券法,公司治理,商业合同,一般公司法,并购,首次公开招股,技术许可和公司财务事务方面的客户。 2018年,在担任DSS内部总法律顾问期间,D'Angelo先生被提名为西纽约日报和罗切斯特商业期刊年度企业法律顾问奖。

              “Sichenzia Ross为我提供了一个完整的过渡,以我作为内部总法律顾问的角色,同时为我提供了
              一个理想的平台,让我继续代表在SRF保护伞下的DSS的外部顾问。我已经认识Greg Sichenzia
              多年了,因为我们一起上过法学院并且在过去一直有专业合作,我很高兴加入一家拥有如此多样
              化的创新上市公司客户名单的全国知名的公司法和证券法律师事务所。” D'Angelo先生。 “我相信,我的经验加上Sichenzia Ross的卓越声誉将帮助我继续发展公司的公司业务。”

              创始合伙人格雷戈里·西申齐(Gregory Sichenzia)对此表示欢迎,他说:“我们很高兴杰夫加入
              。从他担任DSS总法律顾问时,我们就与他有合作,并且知道他具有我们在寻求并吸引的专业性
              和品格。”

              D'Angelo先生持有B.S.普渡大学普通管理专业,本杰明N.卡多佐法学院法律学位。

              Sichenzia Ross Ference LLP
              Latest posts by Sichenzia Ross Ference LLP (see all)

                Sichenzia Ross Ference LLP代表A.G.P / Alliance Global Partners为Cellect Biotechnology Ltd.提供650万美元的公开募股

                cellect logo

                新闻稿 – 纽约州纽约市 – 2019年2月12日 – Sichenzia Ross Ference LLP今天宣布,它代表AGP
                / Alliance Global Partners担任美国存托股份(ADS)和Cellect Biotechnology Ltd认股权证的公
                开发行的唯一账簿管理经理。以色列生物技术公司(纳斯达克股票代码:APOP)。国家证券公
                司和道森詹姆斯证券公司担任此次发行的联合经理。

                continue reading >>

                Sichenzia Ross Ference LLP祝贺Zynex, Inc.在纳斯达克上市

                纽约市,纽约州 – 2019年2月8日 – Sichenzia Ross Ference LLP今天宣布本所代表的Zynex,
                Inc.(纳斯达克股票代码:ZYXI)在纳斯达克资本市场上市。 Sichenzia Ross Ference LLP团队
                由创始合伙人Gregory Sichenzia和合伙人Tara Guarneri-Ferrara领导。本次上市于2019年2月12
                日开始有效交易,ZYXI的普通股将以其现有股票代码“ZYXI”进行交易。

                Sichenzia Ross Ference LLP的合伙人Gregory Sichenzia表示:“我所恭喜ZYXI实现了这一重要
                的里程碑,这一里程碑使公司能够在继续开发疼痛管理和康复电疗设备的同时,充分利用其市场
                目标资本。”

                Sichenzia Ross Ference LLP代表INmune Bio Inc.在纳斯达克资本市场首次公开发行800万美元股票

                inmunebio logo

                新闻稿 – 纽约,纽约 –  2019年2月5日 业内领先的证券和公司律师事务所Sichenzia Ross Ference(“SRF”)很高兴宣布该律所代表INmune Bio Inc.(INMB),一家致力于开发利用患者先天免疫系统对抗疾病疗法的免疫治疗公司,在首次公开发行中以每股8.00美元的价格 获得总收益约为8,000,000美元,并在纳斯达克资本市场上市,股票代码为INMB。

                 

                continue reading >>

                Sichenzia Ross Ference LLP推出Merchant Cash Advance Practice Group

                纽约,2019年1月15日 – 领先的证券和公司律师事务所Sichenzia Ross Ference(“SRF”)今天宣布,该公司已经成立了一个专业实践小组,致力于满足替代商业融资和商业现金的法律需求。 Advance(MCA)公司。

                由Sichenzia Ross Ference合伙人Mendy Piekarski领导,这个多学科团队在MCA商业周期的各个方面建立了专业知识,包括资本形成,资产部署,经纪人提名,联合和参与协议,监管合规和诉讼。

                该团队的成立标志着Sichenzia Ross Ference的业务范围扩展到不断增长的替代商业融资和商业现金发展行业,这是一种为小企业提供创新融资形式的高增长法律实务。

                “为了满足客户的需求并继续提供我们所熟知的尖端解决方案和全面的法律咨询,Sichenzia Ross Ference热情地推出了这个新的实践领域,”创始人Sichenzia Ross Ference的合伙人Gregory Sichenzia说道。 “Mendy和其团队已经拥有该领域的许多客户,并具备替代商业融资和商业现金预付的专业知识和经验,这将使SRF能够扩展为现有和未来客户提供法律服务的范围。”

                Sichenzia Ross Ference LLP
                Latest posts by Sichenzia Ross Ference LLP (see all)

                   

                  Sichenzia Ross Ference LLP代表Boulder Botanicals&Biosciences Laboratories, Inc. ,为其500万美元私募融资提供法律服务

                  boulder botanicals

                  新闻稿 – 纽约,纽约 – 2019年1月5日 – 领先的证券和公司律师事务所Sichenzia Ross Ference(“SRF”)很高兴宣布代表Boulder Botanicals&Biosciences Laboratories, Inc.BBBL)一家控股并经营多家CBD生产,开采和分销行业的公司,以每股1.00美元的价格发行普通股,总收益约为5,000,000美元

                  continue reading >>

                  Sichenzia Ross Ference LLP代表Boustead Securities, LLC,为China SXT Pharmaceuticals, Inc. 首次公开发行1020万美元股票提供法律服务

                  china sxt pharmaceuticals

                  新闻稿 – 纽约纽约– 2019年1月4日 – Sichenzia Ross Ference LLP祝贺中国SXT制药公司(“公司”)(纳斯达克股票代码:SXTC),一家专注于研究,开发,制造,营销中药饮片(“TCMPs”)的专业制药公司,于2019年1月3日完成首次公开发行的最终交割。连同2018年12月31日的首次交割,公司以每股4.00美元的公开发价发行2,546,275股普通股扣除承销折扣,佣金及其他发费用,公司募集了约1,020万美元的总收益。该股票计划于今天下午东部时间2:05左右在纳斯达克资本市场开始交易。股票代码为“SXTC”。

                  continue reading >>

                  Sichenzia Ross Ference LLP代表New Age Beverages Corporation,为其以8500万美元收购Morinda Holdings, Inc.提供法律服务

                  new age beverage corp. logo

                  纽约,2019年1月3日 行业领先的证券和公司律师事务所Sichenzia Ross Ference LLP今宣布其并购团队代表New Age Beverages Corporation(纳斯达克股票代码:NBEV)收购Morinda Holdings, Inc.,一家总部位于犹他州业务遍及全球60多个国家倡导健康饮品和生活方式公司

                  此项收购价格为8500万美元,包括7500万美元现金,以及作价1000万美元2,016,480股New Age的普通股作价以截至2018年12月20该普通股40天成交量加权平均价格为基础进行计算该交易遵守1976年出台并在2018年12月21日修订哈特 – 斯科特 – 罗迪诺反托拉斯改进法案的合并前通知要求

                  continue reading >>

                  Sichenzia Ross Ference LLP代表A.G.P / Alliance Global Partners,为Creative Realities, Inc. 公开发行1000万美元股票提供法律服务

                  creative realities logo

                  新闻稿 – 纽约,纽约 – 2018年11月19日 – Sichenzia Ross Ference LLP今宣布代表AGP / Alliance Global Partners(通过Euro Pacific Capital为其Creative Realities, Inc.(纳斯达克股票代码:CREX普通股股票和认股权证的公开发行作为独家账簿管理人,提供法律服务

                  continue reading >>

                  Sichenzia Ross Ference LLP代表New Age Beverages Corp.,为其公开发行5200万美元股票提供法律服务

                  new age beverage corp. logo

                  新闻稿 – 纽约市,纽约 – 2018年11月14日 – Sichenzia Ross Ference LLP今宣布,已代表New Age Beverages Corporation(纳斯达克股票代码:NBEV)公开发行14,835,000股普通股,其中包括承销商全部同时行权的15%超额配选择,公开发价为每股3.50美元,NBEV的总收益为51,922,500美元。 Roth Capital Partners和A.G.P / Alliance Global Partners担任此次发行的联合账簿管理人

                  continue reading >>

                  Sichenzia Ross Ference代表Pareteum Corporation,为其以最终协议收购iPass, Inc.提供法律服务

                  The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

                  新闻稿 – 纽约,纽约 – 2018年11月13日 美国知名证券和公司法律师事务所Sichenzia Ross Ference LLP今宣布代表Pareteum Corporation(纳斯达克股票代码:TEUM),一云软件平台,iPass, Inc.纳斯达克股票代码:IPAS),一全球移动电话链接供应商,签订了最终协议以收购iPass, Inc.Pareteum预计每年可实现超过1500万美元的成本协同效应预计第一年将实现超过1200万美元的此类协同效应。

                  continue reading >>

                  Sichenzia Ross Ference LLP代表Wize Pharma, Inc., 为其445万美元的私募融资提供法律服务

                  wize pharma

                  纽约,纽约 – 2018年10月24日 – Sichenzia Ross Ference LLP今宣布代表Wize Pharma, Inc.(OTCQB代码:WIZP),一家专注于治疗眼科疾病、处于临床阶段以色列美上市公司,以私募股权方式,通过机构和合格投资者募集了每股1.00美元的3,100,000股普通股和1,350股新发行可以每股1.00美元作价转换的可转换Series A优先股。

                  continue reading >>

                  创始合伙人Gregory Sichenzia被领先的法律贸易出版物引用

                  新闻稿纽约纽约– 2019114领先的证券和公司律师事务所Sichenzia Ross Ference“SRF”)今天表示,创始合伙人Gregory Sichenzia出现在两个领先的法律出版物Law.comLaw.360当中。

                  Law.com的文章中,Greg与记者Christine Simmons分享他对政府关闭如何影响上市公司及其法律顾问的见解。

                  Law360文章(需要订阅)中,GregTom Zanki进行了交谈,讨论了旧金山摩根大通医疗保健会议的内容

                  Sichenzia Ross Ference LLP Represents Rodman & Renshaw a Unit of H.C Wainwright in a $15 Million Upsized Public Offering of Medical Transcript Billing, Corp.

                  mtbc.com logo

                  Press Release – New York, NY – October 15,  2018 – Sichenzia Ross Ference LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright, as Exclusive Placement Agent and Boenning & Scattergood, Inc. as co-placement agent in a public offering of Series A Preferred stock for Medical Transcript Billing, Corp. (MTBC.NASDAQ).

                  continue reading >>

                  Sichenzia Ross Ference Kesner LLP Represents New Age Beverages Corp. in $12 Million Credit Facility

                  new age beverage corp. logo

                  Press Release – New York, NY – August 24, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it has represented New Age Beverages Corporation (NASDAQ “NBEV”) in a loan and security agreement with Siena Lending Group LLC which provides for a $12 million aggregate principal amount revolving credit facility, which is subject to availability based on eligible accounts receivables and eligible inventory of the Company.  The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia, Marcelle Balcombe, Counsel, Kimberly Boler and associate, Grant Levine.

                  Sichenzia Ross Ference Kesner LLP Represents New Age Beverages Corp. in $10.5 Million Underwritten Public Offering

                  new age beverage corp. logo

                  Press Release – New York, NY – August 24, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it has represented New Age Beverages Corporation (NASDAQ “NBEV”) in a public offering of 8.2 million shares of its common stock at a price of $1.28 per share for gross proceeds to NBEV of $10.5 million. Roth Capital Partners acted as sole book running manager and Northland Capital Markets acted as Lead Manager for the offering.  The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia, Marcelle Balcombe, and Tara Guarneri-Ferrara.

                  Sichenzia Ross Ference LLP Represents ThinkEquity, a division of Fordham Financial Management as Sole Book-Running Manager on $10 Million Public Offering of Securities of  FlexShopper, Inc.

                  flexshopper

                  Press Release – New York, NY – October 1, 2018 – Sichenzia Ross Ference LLP announced today that it has represented ThinkEquity, a division of Fordham Financial Management, Inc. as sole book-running manager in an underwritten public offering of $10 Million of Units of FlexShopper, Inc. (Nasdaq FPAY).

                  continue reading >>

                  Sichenzia Ross Ference Kesner LLP以4.75美元的债务交易代表New Age Beverages Corporation

                  new age beverage corp. logo

                  Press Release – New York, NY – June 20, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it represented New Age Beverages Corporation (“NASDAQ. NBEV”), a Colorado based organic and natural healthy beverage company in a $4.75 million senior secured convertible promissory note transaction. A portion of the proceeds were used to repay the Company’s line of credit with US Bank. The Company also converted debt held by Sunkist Growers, Inc. an agricultural marketing cooperative, into shares of its common stock.

                  The Sichenzia Ross Ference Kesner LLP team was led by Partners, Gregory Sichenzia and Marcelle Balcombe and Of Counsel, Kimberly Boler.

                  Sichenzia Ross Ference Kesner律师事务所代表ThinkEquity,福特汉姆财务管理部门作为独家账簿管理经理,以1800万美元公开发行Trovagene,Inc。的证券

                  trovagene logo

                  Press Release – New York, NY – June 12, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it has represented ThinkEquity, a division of Fordham Financial Management, Inc., as sole book-running manager on its first underwritten public offering since launching its new ThinkEquity division.

                  continue reading >>

                  Sichenzia Ross Ference Kesner LLP代表Pareteum公司以6.1百万美元注册直接发售

                  The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

                  纽约州纽约-2018年5月14日电 – 国家认可的证券和公司律师事务所,Sichenzia Ross Ference Kesner律师事务所今天宣布,它代表着移动网络软件和服务的领先国际供应商Pareteum Corporation(纽约证券交易所股票代码:TEUM)网络和物联网市场,注册直接发售2,440,000股普通股。每股收购价格为2.50美元。 Pareteum获得总收益610万美元。

                  continue reading >>

                  Sichenzia Ross Ference Kesner LLP代表Acolyte Group将其LED照明业务出售给CapStreet Private Equity Group

                  acolyte group

                  May 2, 2018 — New York, NY.  Sichenzia Ross Ference Kesner LLP (“SRFK”) represented The Acolyte Group, a New York based provider of fully integrated LED lighting systems in the sale of its entire business to General LED, a portfolio company of Houston Texas based private equity firm Cap Street Group.

                  The SRFK team was led by Partners Thomas Rose and Gregory Sichenzia and Counsel Jeff Cahlon with assistance from Counsel Todd Manister from the SRFK Real Estate Group.

                  Sichenzia Ross Ference LLP

                  Sichenzia Ross Ference Kesner LLP代表A.G.P / Alliance Global Partners(通过Euro Pacific Capital)以600万美元公开发行Cocrystal Pharma,Inc.的普通股。

                  cocrystal pharma

                  Press Release – New York, NY – May 3rd, 2018 –  Sichenzia Ross Ference Kesner LLP announced today that it has represented A.G.P/ Alliance Global Partners  (through Euro Pacific Capital) as sole book running manager in the underwritten public offering of shares of Common Stock of Cocrystal Pharma, Inc. (NASDAQ: COCP). Cocrystal sold an aggregate of 4,210,527 shares of Common Stock at a price of $1.90 per share.   Cocrystal is a clinical stage biotechnology company seeking to discover and develop novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. The Sichenzia Ross Ference Kesner LLP team was led by partners Marc Ross, Avital Perlman and Tom Rose.

                  Sichenzia Ross Ference LLP

                  Sichenzia Ross Ference Kesner LLP代表Sunworks,Inc.以375万美元的债务交易进行交易

                  sunworks solar power

                  Press Release – New York, NY – April 27, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it represented Sunworks, Inc. (“NASDAQ. SUNW”), a premier provider of high performance solar power systems, in a $3.75 million two year term loan transaction. The lender is CrowdOut Capital LLC. Management, including the Chief Financial Officer, also participated in $750,000 of the loan amount.

                  The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia and Marcelle Balcombe.

                  Sichenzia Ross Ference LLP

                  Sichenzia Ross Ference Kesner LLP代表New Age Beverages Corp.以400万美元承销公开发售

                  new age beverage corp. logo

                  Press Release – New York, NY – April 12, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it has represented New Age Beverages Corp.  (NASDAQ “NBEV”) in a public offering of 2,285,715 million shares of its common stock at a price of $1.75 per share for gross proceeds to NBEV of $4,000,000.A.G.P/ Alliance Global Partners  (Euro Pacific Capital) and Maxim Group L.L.C. acted as the Joint Book Running Managers for the offering.  The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia, Marcelle Balcombe, and Counsel Jeff Cahlon.

                  Sichenzia Ross Ference LLP

                  Sichenzia Ross Ference Kesner LLP代表Rodman&Renshaw代表Rodman&Renshaw成为H.C Wainwright的一个部门,该公司以105万美元医疗记录账单公开发行

                  mtbc.com logo

                  Press Release – New York, NY – April 11, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright, as Exclusive Placement Agent and Boenning & Scattergood, Inc. as co-placement agent in a public offering of Series A Preferred stock for Medical Transcript Billing, Corp. (MTBC.NASDAQ).

                  continue reading >>

                  Sichenzia Ross Ference Kesner LLP代表AYTU Bioscience,Inc.以1200万美元公开募股

                  aytu bioscience

                  新闻稿 – 纽约州纽约市-2018年3月6日-Schhenzia Ross Ference Kesner LLP今天宣布,该公司已代表AYTU Bioscience,Inc.(“纳斯达克股票代码:AYTU”)以1,200万美元公开发售A类股,其中包括普通股以及包括B系列优先股和权证的权证和B类单位。以每件$ 0.45的价格出售总共19,520,000个A类单元,以每件$ 1,000的价格出售3,216个B类单元。认股权证可以每股0.54美元的价格行使,期限为5年。 Joseph Gunnar&Co.担任独家管理主承销商,福特汉姆财务管理有限公司担任主管主承销商。

                  continue reading >>

                  Sichenzia Ross Ference Kesner LLP代表MoneyOnMobile,Inc.以500万美元的私人配售

                  moneyonmobile-logo

                  新闻稿 – 纽约州纽约市 –  2018年2月12日–Schhenzia Ross Ference Kesner LLP今天宣布,它代表全球移动支付技术和加工公司MoneyOnMobile,Inc.(简称“MOMT”)以私人配售方式与经认证的投资者其中MOMT收到4,998,000美元,用于发行1,666股H系列优先股,以及五年期权证以每股0.50美元的行权价购买3,332,000股普通股。

                  continue reading >>

                  Sichenzia Ross Ference Kesner LLP代表Roth Capital Partners和布鲁克莱恩证券(Brookline Securities)共同出资550万美元在QBIO Med。

                  QBioMed

                  新闻稿 – 纽约州纽约市-2018年2月1日–Schhenzia Ross Ference Kesner律师事务所今天宣布,它已代表罗斯资本合伙人有限责任公司(Roth Capital Partners LLC)担任首席定位代理人和CIM /布鲁克莱恩证券公司(Brookline Securities) QBIO Med,Inc.(OTC.QBIO)的股票和权证系列。 QBIO是一家生物技术加速和开发公司,专注于获取和授权生命科学治疗产品。

                  continue reading >>

                  Sichenzia Ross Ference Kesner LLP代表Vuzix Corporation以3000万美元以上的市场注册直接销售

                  vuzix view the future logo

                  新闻稿 – 纽约州纽约市 –  2016年1月26日 –  Sichenzia Ross Ference Kesner律师事务所今天宣布,该公司代表Vuzix Corporation(纳斯达克股票代码:VUZI)代表其注册股票以3,000美元注册普通股股票每股10.00美元,以及1,200,000股一年期普通股购买权证,每股行使价10.00美元,所得款项总额为Vuzix 30,000,000美元。 Chardan Capital Markets LLC担任此次发行的独家配售代理。 Sichenzia Ross Ference Kesner LLP团队由Partners Gregory Sichenzia,Thomas Rose和律师Jeff Cahlon领导。

                  Sichenzia Ross Ference LLP

                   

                  Sichenzia Ross Ference Kesner LLP Represents Biotricity Inc. in $2.5 Million Registered Direct Offering

                  biotricity logo

                  Press Release – New York, NY – December 22, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Biotricity Inc. (OTCQB:BTCY”) in a Registered Direct public offering of 450,164 registered shares of its common stock at a price of $5.50 per share for aggregate proceeds of approximately $2.5 million.

                  The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia and David Manno.

                  Sichenzia Ross Ference LLP

                  Sichenzia Ross Ference Kesner LLP Represents Vuzix Corporation in $12.5 Million Registered Direct Offering

                  Vuzix Corporation

                  Press Release – New York, NY – December 18, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Vuzix Corporation (NASDAQ “VUZI”) in a Registered Direct public offering of 2,066,116 million registered shares of its common stock at a price of $6.05 per share and 1,033,058 3-year common stock purchase warrants with an exercise price of $7.00 per share  for gross proceeds to Vuzix of $12,500,000.

                  continue reading >>

                  Sichenzia Ross Ference Kesner LLP Represents Rodman & Renshaw, a unit of H.C Wainwright, in a $3.9 Million Public Offering of Medical Transcript Billing, Corp.

                  mtbc.com logo

                  Press Release – New York, NY – December 11, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright, as Exclusive Placement Agent and Boenning & Scattergood, Inc. as co-placement agent in a public offering of Series A Preferred stock for Medical Transcript Billing, Corp. (MTBC.NASDAQ).

                  continue reading >>

                  Sichenzia Ross Ference Kesner LLP Represents Pareteum Corporation in $6.58 Million Registered Direct Offering and Concurrent Private Placement

                  The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

                  Press Release – New York, NY – December 6, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it represented Pareteum Corporation (NYSE American: “TEUM”), a leading international provider of mobile networking software and services to the Mobile Network and Internet of Things markets, in a registered direct offering and private placement offering of 7,151,146 shares of common stock and restricted five-year warrants to purchase up to 7,151,146 shares of common stock exercisable at $1.09 per warrant.

                  continue reading >>

                  Sichenzia Ross Ference Kesner LLP Represents Pareteum Corporation in $12.0 Million Firm Commitment Public Offering

                  The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

                  Press Release – New York, NY – November 9, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it represented Pareteum Corporation (NYSE American: “TEUM”), a leading international provider of mobile networking software and services to the Mobile Network and Internet of Things markets, in a firm commitment underwritten offering of 9,009,478 shares of common stock, 4,034 shares of preferred stock (each of which shares is an equivalent of 920 shares of common stock), and five-year warrants to purchase up to 7,478,228 shares of common stock exercisable at $1.05 per warrant.

                  continue reading >>

                  Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar and Fordham Financial Management in $6.75 Million Registered Direct Offering of Common Stock of Ampio Pharmaceuticals, Inc.

                  ampio pharmaceuticals

                  Press Release – New York, NY – October 18, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Joseph Gunnar & Co.  as Lead Placement Agent and Fordham Financial Management Co-Placement Agent  in a $6.75 million Registered Direct Public Offering of Common Stock of Ampio Pharmaceuticals, Inc. (“NYSE.AMPE”).

                  continue reading >>

                  Sichenzia Ross Ference Kesner LLP Represents Pareteum Corporation in $1.56 Million Shelf Take Down

                  The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

                  Press Release – New York, NY – October 12, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Pareteum Corporation (“Pareteum”), a rapidly growing mobile Cloud Communications Platform company, in connection with its shelf take down of 1,495,000 shares of its common stock. Gross proceeds to Pareteum from this offering are $1,569,750 before deducting placement agent’s commissions and other expenses.  Dawson James Securities acted as placement agent for the offering.

                  The Sichenzia Ross Ference Kesner LLP team was led by Partner Darrin M. Ocasio, Counselors Jeffrey Cahlon, and Cheryll J. Calaguio and Associate Evan Berger.

                  Sichenzia Ross Ference LLP

                  Sichenzia Ross Ference Kesner LLP Represents Rodman & Renshaw a unit of H.C Wainwright in a $6.0 Million Public Offering of Medical Transcript Billing, Corp.

                  mtbc.com logo

                  Press Release – New York, NY – September 28, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright, as Exclusive Placement Agent and Boenning & Scattergood, Inc. as co-placement agent in a public offering of Series A Preferred stock for Medical Transcript Billing, Corp. (MTBC.NASDAQ).

                  continue reading >>

                  Sichenzia Ross Ference Kesner LLP Real Estate Group Represents One Wall Partners in a $63 Million, 16-Building, Portfolio Acquisition

                  one wall partners

                  Press Release – New York, NY – September 20, 2017 – The real estate practice group of SRFK announced today that it recently closed on a $63 million, 16 building, multi-family, portfolio acquisition for One Wall Partners.  One Wall Partners is a vertically integrated real estate investment firm that specializes in the acquisition, development and management of transit-oriented workforce housing.  The Sichenzia Ross Ference Kesner LLP team was led by partner Anthony Ficara, counsel Michael Wickersham and associate Laura Kim.

                  Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar & Co., LLC in $10 Million Public Offering of American Depository Shares of BiondVax Pharmaceuticals Ltd. (Israel)

                  biondvax pharmaceuticals

                  Press Release – New York, NY – September 19, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Joseph Gunnar & Co., LLC. as sole book running manager in the underwritten public offering of American Depository Shares (ADS’s) of BiondVax Pharmaceuticals, Ltd. (NASDAQ: BVXV, TASE BVXV), a clinical stage biopharmaceutical company focused on developing a universal flu vaccine. The public offering consisted of 1,500,000 ADS’s and the full overallotment of 166,667 additional ADS’s at a public offering price of $6.00 per ADS for gross proceeds of $10 million.  The Sichenzia Ross Ference Kesner LLP team was led by partners Gregory Sichenzia and Avital Perlman, Counsel Jeffrey Cahlon and Associate Evan Berger.

                  Sichenzia Ross Ference Kesner LLP Represents Aegis Capital Corp. in $6 Million Public Offering of Units of Precipio, Inc.

                  precipio diagnostics

                  Press Release – New York, NY – August 23rd, 2017 –  Sichenzia Ross Ference Kesner LLP announced today that it has represented Aegis Capital Corp. as sole book running manager in the underwritten public offering of Units of Precipio, Inc. (NASDAQ: PRPO). Each Unit is comprised of 1 share of Series B Preferred Stock which is convertible into 400 shares of common stock at a price of $2.50 per share and one warrant to purchase 400 shares of common stock at $3.00 per share.   Precipio provides diagnostic information to physicians and there patients worldwide.  The Sichenzia Ross Ference Kesner LLP team was led by partner Tom Rose and counsel Jeff Cahlon.

                  Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar and Fordham Financial Management in $11.8 PIPE financing of Aytu Bioscience, Inc.

                  aytu bioscience

                  Press Release – New York, NY – November 2, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Joseph Gunnar & Co.  as lead placement agent and Fordham Financial Management, Inc. co-placement agent  in a private placement offering of equity securities of Aytu BioScience, Inc.  (OTC Market “AYTU”).

                  continue reading >>

                  Sichenzia Ross Ference Kesner LLP Represents Vuzix Corporation in $8.6 Million Registered Direct Offering

                  vuzix view the future logo

                  Press Release – New York, NY – August 14, 2016 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Vuzix Corporation (NASDAQ “VUZI”) in a Registered Direct public offering of 1.5 million registered shares of its common stock at a price of $5.75 per share  for gross proceeds to Vuzix of $8,625,000.Chardan Capital Markets LLC acted as the exclusive Placement Agent for the offering.  The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia, Thomas Rose, and Counsel Jeff Cahlon.

                  Sichenzia Ross Ference Kesner LLP Represents JetSmarter Inc. in Institutional Investment from Clearlake Capital Group and Leucadia National Corporation

                  jetsmarter_logo

                  Press Release — August 10, 2017 — New York, NY — Sichenzia Ross Ference Kesner LLP represented JetSmarter Inc., an innovative technology company and market leader in the premium private-flight-sharing economy, in an institutional capital raise.  The investment was anchored by lead sponsor, Clearlake Capital Group, L.P. and included participation from Leucadia National Corporation and existing investors.  Jefferies LLC acted as the exclusive placement agent to JetSmarter Inc. in connection with the financing.

                  continue reading >>

                  Sichenzia Ross Ference Kesner LLP Represents CloudCommerce, Inc., in Acquisition of Parscale Creative, Inc.

                  cloudcommerce inc

                  Press Release – New York, NY – August 2, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented CloudCommerce, Inc., a global provider of cloud-driven e-commerce and mobile commerce solutions, in its acquisition of Parscale Creative, Inc., a company engaged in the digital marketing business, through a forward triangular merger with Parscale Digital, Inc., a newly formed wholly owned subsidiary of CloudCommerce, Inc.

                  continue reading >>

                  思成律师事务所成功代理2000万美元证券公开发行

                  china internet nationwide financial services

                  新闻稿纽约市,纽约州 – 2017731 在全国享誉盛名的证券法与公司法律师事务所,Sichenzia Ross Ference Kesner LLP(思成律师事务所),今日宣布其成功代理China Internet Nationwide Financial Services Inc.NASDAQCIFS)进行首次公开发行China Internet Nationwide Financial Services Inc.是一家向需要金融支持的广大中国中小企业提供金融咨询服务的公司。本次发行共计2,023,146股普通股,每股股价10.00美元共募集20,231,460美元 公司股票预计将于201788日在纳斯达克全球市场开始交易,交易代码为CIFS

                  本次发行由思成律师事务所合伙人Benjamin Tan 以及Will Rao律师领导发行。

                  Sichenzia Ross Ference LLP

                  Sichenzia Ross Ference Kesner LLP Represents Rodman & Renshaw a unit of H.C Wainwright in a $7.4 Million Public Offering of Medical Transcript Billing, Corp.

                  mtbc - medical transcription billing corp. logo

                  Press Release – New York, NY – June 23, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright, as Exclusive Placement Agent and Boenning & Scattergood, Inc. as co-placement agent in a public offering of Series A Preferred stock for Medical Transcription Billing, Corp. (MTBC.NASDAQ). MTBC is a principal provider of proprietary, cloud-based electronic health records, practice management, and mHealth solutions.

                  continue reading >>

                  Sichenzia Ross Ference Kesner LLP Represents XTL Biopharmaceuticals Ltd. in $2.5 Million Registered Direct Offering

                  xtlbio logo

                  Press Release – New York, NY – February 27, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented XTL Biopharmaceuticals, Ltd. (NASDAQ: XTLB) (TASE: XTL.TA), an Israeli clinical-stage biopharmaceutical company developing treatments for autoimmune diseases, in a registered direct offering of 1,000,000 American Depository Shares (“ADSs”) at a price of $2.50 per share and unregistered warrants to purchase 1,000,000 ADSs at an exercise price of $4.10 per ADS for gross proceeds of $2,500,000. continue reading >>

                  Sichenzia Ross Ference Kesner LLP Represents Immuron Limited on $6.1M IPO and NASDAQ listing

                  immuron

                  Press Release — New York, NY — June 14, 2017 — Sichenzia Ross Ference Kesner LLP (“SRFK”) announced today the Firm has represented Immuron Limited (NASDAQ: IMRN) (ASX : IMC), a clinical-stage biopharmaceutical company focused on NASH and OTC products, on the company’s U.S. underwritten public offering of American Depository Shares (ADSs) and warrants to purchase the company’s ADSs at a combined offering price of $10.00.

                  continue reading >>

                  Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar, and Fordham Financial Management in $6.6 Registered Direct offering of Ampio Pharmaceuticals, Inc.

                  ampio pharmaceuticals

                  Press Release – New York, NY – June 8, 2017 – Nationally recognized securities and corporate law firm, Sichenzia Ross Ference Kesner LLP, announced today that it has represented Joseph Gunnar & Co. as Lead Placement agent and Fordham Financial Management as Co-Placement Agent  in a $6.6 million Registered Direct public offering of equity securities of Ampio Pharmaceuticals, Inc.(“NYSE MKT.AMPE”).

                  continue reading >>

                  Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar & Co. and Brookline Capital Markets in a $13.25 PIPE for MRI Interventions, Inc.

                  mri interventions

                  Press Release – New York, NY – May 26, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Joseph Gunnar & Co., LLC, as lead Placement Agent and Brookline Capital Markets, a division of CIM Securities, LLC, as co-Placement Agent in a $13.25 Million PIPE transaction for MRI Interventions, Inc. (OTCQB: MRIC) a medical device company that is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain.

                  continue reading >>

                  Sichenzia Ross Ference Kesner LLP Represents Tonix Pharmaceuticals Holding Corp. in $8 Million Shelf Take Down

                  tonix pharmaceuticals

                  Press Release – New York, NY – April 8, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Tonix Pharmaceuticals Holding Corp. (“Tonix”), a company that is developing innovative pharmaceutical products to address public health challenges, in connection with its underwritten public offering of 1,800,000 shares of its common stock at an offering price of $4.45 per share of common stock.

                  continue reading >>

                  Sichenzia Ross Ference Kesner LLP Represents XTL Biopharmaceuticals Ltd., in a $2.8 Million Private Placement of ADSs.

                  xtlbio logo

                  Press Release – New York, NY – March 22, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented XTL Biopharmaceuticals Ltd.  (“XTLB. NASDAQ”), an Israeli biopharmaceutical company engaged in the acquisition and development of pharmaceutical drugs for the treatment of lupus and other autoimmune diseases, in a private placement offering with existing investors where XTLB issued 1,400,000 American Depository Shares (ADSs) at a purchase price of $2.00 per ADS.

                  continue reading >>

                  Sichenzia Ross Ference Kesner LLP Represents Rodman & Renshaw a unit of H.C Wainwright in $3.85 Million Public Offering of Innovus Pharmaceuticals, Inc.

                  innovus pharma

                  Press Release – New York, NY – March 21, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Rodman & Renshaw a unit of H.C. Wainwright as Exclusive Placement Agent in the public offering of common stock and Warrants of Innovus Pharmaceuticals, Inc. (“INNV.OTC).

                  continue reading >>

                  Sichenzia Ross Ference Kesner LLP Represents Pareteum Corporation in $3.5 Million Public Offering

                  The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

                  Press Release – New York, NY – March 20, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it represented Pareteum Corporation (NYSEMKT: “TEUM”), a leading international provider of mobile networking software and services to the Mobile Network and Internet of Things markets, in an underwritten public offering of 2,333,334 shares of common stock at a public offering price of $1.50 per share together with the issuance of 1,166,667 five year warrants to purchase common stock with an exercise price of $1.87.

                  continue reading >>

                  Sichenzia Ross Ference Kesner LLP Represents Cannabinoid Based Therapeutics Company in $12.3 Million Private Placement Led by Tuatara Capital Fund I, Ltd.

                  Press Release – New York, NY – March 2, 2017 – Securities and corporate law firm Sichenzia Ross Ference Kesner LLP is pleased to announce that the firm has represented a cannabinoid based life sciences corporation whose technology is designed to synthetically produce medically beneficial cannabinoids without utilizing the actual cannabis plant for the customized treatment of disease. continue reading >>

                  Sichenzia Ross Ference Kesner LLP Represents Aegis Capital Corp. and Laidlaw & Company (UK) Ltd. in $4.8 Million Public Offering

                  functionx logo

                  Press Release – New York, NY – February 28, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Aegis Capital Corp. and Laidlaw & Company (UK) Ltd. as joint book-running managers in the underwritten public offering of common stock of Function(x) Inc. (NASDAQ: FNCX).  Function(x) operates Wetpaint.com and Rant.

                  continue reading >>

                  Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar and Fordham Financial Management as Warrant Agent in $2.3 Million Warrant Exchange and Exercise for AYTU BioScience, Inc.

                  aytu bioscience

                  Press Release – New York, NY – February 28, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Joseph Gunnar & Co., LLC and Fordham Financial Management, Inc. as warrant solicitation agents in a $2.3 warrant exchange and exercise for Aytu Bioscience, Inc. (OTCQB “AYTU”).

                  continue reading >>

                  Sichenzia Ross Ference Kesner LLP Represents Vycor Medical Inc. in an Internet Portal-based Private Placement

                  vycor medical inc.

                  Press Release – New York, NY – January 13, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Vycor Medical Inc. (OTCQB:VYCO) in a private placement with the Company’s existing accredited investor shareholders that was conducted  through an internet portal through which the Company provided potential investors with the offering  documents and accepted subscriptions.  The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia and David Manno.

                  continue reading >>

                  Sichenzia Ross Ference Kesner LLP Represents Oppenheimer & Co. in $3.6 Million PIPE for Ener-Core, Inc.

                  ener-core

                  Press Release – New York, NY – December 5, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Oppenheimer & Co., as Sole Placement Agent in private placement of $3.6 Million principal amount of convertible senior secured notes and warrants of Ener-Core, Inc.  (OTCQB. “ENCR”).

                  continue reading >>

                  Sichenzia Ross Ference Kesner LLP Represents Vuzix Corporation in $14.5 Million Registered Direct Offering.

                  vuzix view the future logo

                  Press Release – New York, NY – December 2, 2016 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Vuzix Corporation (NASDAQ “VUZI”) in a Registered Direct public offering of 2 million registered shares of its common stock at a price of $7.25 per share for gross proceeds to Vuzix of $14,500,000. Chardan Capital Markets LLC acted as the exclusive Placement Agent for the offering. The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia, Thomas Rose, Marcelle Balcombe and Counsel Jeff Cahlon.

                  Sichenzia Ross Ference Kesner LLP Represents Oppenheimer & Co. and Feltl and Company in $13.5 Million PIPE for Midwest Energy Emissions Corp.

                  midwest energy

                  Press Release – New York, NY – November 18, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Oppenheimer & Co., as lead Placement Agent and Feltl and Company as Co-Placement Agent in a private placement offering of Common Stock of Midwest Energy Emissions Corp. ME2C (OTCQB. “MEEC”). continue reading >>

                  Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar, Feltl and Company and Fordham Financial Management in $8.6 Million Public Offering of Aytu Bioscience, Inc.

                  aytu bioscience

                  Press Release – New York, NY – November 2, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Joseph Gunnar & Co. and Feltl and Company as Joint Book -Running Managers and Fordham Financial Management, Inc. as Lead Manager in a firm commitment underwritten public offering of equity securities of Aytu BioScience, Inc.

                  continue reading >>

                  Sichenzia Ross Ference Kesner LLP Represents ToughBuilt Industries, Inc. in $6.1 Million Private Offering

                  toughbuilt logo

                  Press Release – New York, NY – October 18, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented ToughBuilt Industries, Inc. (“ToughBuilt”) in a private placement of equity as well as debt securities.  ToughBuilt is a private company that markets and distributes various home improvement and construction product lines for both do-it-yourself and professional markets under the TOUGHBUILT® brand name within the global multi-billion dollar per year tool market industry.

                  continue reading >>

                  Sichenzia Ross Ference Kesner LLP Represents ABT Holdings, Inc. in $5 Million Private Offering of Senior Secured Convertible Debentures

                  abt logo

                  October 17, 2016 — New York, NY — Sichenzia Ross Ference Kesner LLP has represented ABT Holdings, Inc. (OTC.PK: ABOT), a diversified holding company engaged in investing, acquiring, developing, and growing various businesses, in a private offering of $5 Million of Senior Secured Convertible Debentures. continue reading >>

                  Sichenzia Ross Ference Kesner LLP Represents Laidlaw & Company (UK) Ltd. as Placement Agent for a $3 Million Private Placement

                  fte networks logo

                  Press Release – New York, NY – October 17, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Laidlaw & Company (UK) Ltd. as the exclusive placement agent in a private placement of equity securities of FTE Networks, Inc. (OTCQX: FTNW), continue reading >>

                  Sichenzia Ross Friedman Ference LLP Represents Network 1 Securities in $7.7 Million IPO and NASDAQ listing of ShineCo, Inc.

                  shineco inc

                  Press Release – New York, NY – September 30, 2016 – Sichenzia Ross Friedman Ference LLP announced today that it represented Network 1Financial Securities, Inc. as underwriter in a $7.7 million best efforts Initial Public Offering of 1,713,190 shares of common stock of ShineCo, Inc. (Nasdaq TYHT) at a public offering price of $4.50 per share. Monarch Bay Securities participated as a selected dealer. Shineco is a producer and distributor of Chinese herbal medicines, organic agricultural produce and other health based plant products in China. The Sichenzia Ross Friedman Ference LLP team was led by Partners Marc Ross and Henry Nisser.

                  continue reading >>

                  Sichenzia Ross Friedman Ference LLP Represents BioPharmX Corporation in $930,000 Registered Direct Offering

                  biopharmx

                  Press Release – New York, NY – September 29, 2016 – Sichenzia Ross Friedman Ference LLP announced today that it has represented BioPharmX Corporation (NYSE. MKT “ BPMX) in a Registered Direct public offering of 1,550,000 registered shares of its common stock at a price of $.60 per share and 1,240,000 unregistered warrants to purchase common stock at an exercise price of $.75 per share for gross proceeds to BPMX of $930,000. Rodman & Renshaw a Unit of H.C. Wainwright & Co., LLC acted as the exclusive Placement Agent for the offering.  The Sichenzia Ross Friedman Ference LLP team was led by Partners Gregory Sichenzia, Marcelle Balcombe and Counsel Jeff Cahlon.

                  continue reading >>